Long term tolerability of high dose ergoline derived dopamine agonist therapy for the treatment of Parkinson’s disease

The latter notion encouraged us to examine the dose of the DAs used to treat PD in routine clinical practice. [...]we systematically reviewed the database of all the PD patients under our care in order to identify those receiving DA therapy (cabergoline, pergolide, pramipexole, or ropinirole) above...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neurology, neurosurgery and psychiatry neurosurgery and psychiatry, 2002-11, Vol.73 (5), p.602-603
Main Authors: Navan, P, Bain, P G
Format: Article
Language:English
Subjects:
Adult
Aged
Cabergoline
Clinical medicine
Dopamine
dopamine agonist
Dopamine Agonists - administration & dosage
Dopamine Agonists - therapeutic use
Drug Administration Schedule
Drug dosages
Drug Tolerance
Ergolines - administration & dosage
Ergolines - therapeutic use
Female
Humans
Letter
Male
Middle Aged
Parkinson Disease - drug therapy
Parkinson's disease
pergolide
Pergolide - administration & dosage
Pergolide - therapeutic use
Randomized Controlled Trials as Topic
Systematic review
Time
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The latter notion encouraged us to examine the dose of the DAs used to treat PD in routine clinical practice. [...]we systematically reviewed the database of all the PD patients under our care in order to identify those receiving DA therapy (cabergoline, pergolide, pramipexole, or ropinirole) above their maximum recommended therapeutic daily dose (respectively 6 mg, 5 mg, 4.5 mg, and 24 mg per day).
ISSN:0022-3050
1468-330X
DOI:10.1136/jnnp.73.5.602